InvestorsHub Logo
Followers 483
Posts 61598
Boards Moderated 14
Alias Born 09/20/2001

Re: None

Saturday, 09/21/2019 11:43:14 AM

Saturday, September 21, 2019 11:43:14 AM

Post# of 14953
This stock is really difficult to evaluate...


Sorrento Contributes To The Formation Of Celularity, Inc. For Breakthrough Placental Therapeutic Platform In Consortium With Leading Pharmaceutical Companies
New Biotechnology Company Accelerates the Delivery of Transformative Innovations in Treatments of Cancer, Inflammatory & Degenerative Diseases, and Functional Regeneration

Contributions of Capital, More Than 200+ Issued and Pending Patents, Pre-Clinical and Clinical Assets and Commercial Products Obtained from Companies Including Celgene Corporation, Sorrento Therapeutics (Nasdaq: SRNE), United Therapeutics, and Human Longevity, Inc

More...


prnewswire.com/news-releases/sorrento-contributes-to-the-formation-of-celularity-inc-for-breakthrough-placental-therapeutic-platform-in-consortium-with-leading-pharmaceutical-companies-300507324.html